# Ehome Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ehome-health

- Industry: Medical Devices & Equipment
- Headquarters: Changsha, China
- Website: www.ehomepoct.com
- Total disclosed funding: $10M
- Latest round: Series D (Aug 23, 2024)
- Investors on record: 8

## About

Established in 2014 and based in Changsha, China, Ehome Health is a medical health company that provides instant testing equipment for primary medical institutions. The company has a production base of over 5,000 square meters and a million-level production workshop. It has more than 60 patents and has been recognized as a national high-tech enterprise and a Hunan Specialized, Refined, Featured and Original SME. In August 2024, the company closed a series D funding from Hunan Xingxiang Investment Holding Group and Changsha Huding Private Equity Fund Management.

The company has developed reagent card incubator, automatic sample processing system, immunochromatographic analyser, multifunctional sample analyser and other product series. Its main product, Palm Measure Portable Mobile Rapid Diagnostic Instrument, can be used to detect inflammation, gastric disease, reproductive health and so on. It has also developed the Yi Academy medical education platform, which promotes academic exchanges between primary care doctors and doctors in large hospitals through online series and live interactive courses. Its medical testing products have served more than 30,000 primary care organisations.

The company generates revenue by developing and selling intelligent portable instant bedside testing devices, providing medical testing services to primary care organisations.

The company will use the series D funding to research and development of products, enhancement of product technology and market development.

## Funding rounds

- Series D, Aug 23, 2024 — Hunan Xingxiang Investment Holding Group, Changsha Huding Private Equity Fund Management
- Series C, Jun 10, 2022 — Kinzon Capital, Joy Capital
- Series B, Aug 16, 2021 — YuanBio Venture, Joy Capital, Guochuang Industry Investment, Esencia Fund
- Series B, Mar 23, 2021, $10M — Joy Capital
- Series A, Sep 26, 2019 — Purple Cow Startups

## Investors

- Purple Cow Startups (https://capitalatlas.ai/funds/purple-cow-startups) — Series A
- Joy Capital (https://capitalatlas.ai/funds/joy-capital) — Series B, Series C
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B
- Guochuang Industry Investment (https://capitalatlas.ai/funds/guochuang-industry-investment) — Series B
- Esencia Fund — Series B
- Kinzon Capital (https://capitalatlas.ai/funds/kinzon-capital) — Series C
- Hunan Xingxiang Investment Holding Group (https://capitalatlas.ai/funds/hunan-xingxiang-investment-holding-group) — Series D
- Changsha Huding Private Equity Fund Management (https://capitalatlas.ai/funds/changsha-huding-private-equity-fund-management) — Series D